Understanding PTEN Hamartoma Tumor Syndrome (PHTS)
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
PTEN hamartoma tumor syndrome (PHTS) is a group of genetic syndromes caused by a mutation in the PTEN tumor suppressor gene. It leads to hamartomas (benign growths) and a higher risk of certain cancers. The main syndromes are Cowden syndrome, usually diagnosed in adults, and Bannayan-Riley-Ruvalcaba syndrome, usually diagnosed in children. Management means lifelong cancer surveillance and multidisciplinary care for physical and developmental symptoms.
Quick Answer
PTEN hamartoma tumor syndrome (PHTS) is a rare genetic condition caused by a mutation in the PTEN gene, which normally regulates cell growth. It causes benign, tumor-like growths called hamartomas throughout the body and significantly raises the risk of breast, thyroid and kidney cancer. Management centers on lifelong cancer screening and treating symptoms such as skin growths and developmental delays. [1]
What the research says
Lifetime cancer risk is high, though estimates vary. A review of nine cohort studies (four independent PHTS cohorts) reported cumulative lifetime risks of any cancer of 81% to 90%, with female breast cancer at 67% to 85% by age 60–70, endometrial cancer 19% to 28%, thyroid cancer 6% to 38%, renal cancer 2% to 24%, colorectal cancer 9% to 32%, and melanoma 0% to 6%; the authors caution that the estimates should be interpreted carefully because of study design and case selection (Hendricks et al., Clin Genet, 2021).
Bowel polyps are common, and colorectal cancer risk is raised. Among 156 PTEN mutation carriers from 101 families, 49 (31%) had benign gastrointestinal polyps, the cumulative risk of benign polyps was 70% by age 60, and the cumulative risk of colorectal cancer was 18% by age 60, leading the authors to recommend colorectal screening starting at age 40 (Nieuwenhuis et al., Colorectal Dis, 2012).
Guidelines call for appropriate surveillance and multispecialty care. Clinical guidelines for Cowden syndrome/PHTS state that patients have a high risk of breast, thyroid, colorectal, endometrial, and renal cancers and need surveillance for early diagnosis, and that the syndrome can be found through multigene panel testing in people with cancer (Takayama et al., J Anus Rectum Colon, 2023).
Research summaries are based on article abstracts retrieved from PubMed.
What Is PHTS?
PTEN hamartoma tumor syndrome (PHTS) refers to a cluster of syndromes linked by a mutation in the PTEN gene. This gene is an important tumor suppressor that makes an enzyme responsible for preventing uncontrolled cell division. When the gene is mutated, cells can grow unchecked, leading to hamartomas, which are noncancerous, tumor-like growths, and raising the likelihood of malignant tumors. [1]
Historically, the conditions under the PHTS umbrella were seen as separate disorders. Today they are grouped together because they share a genetic cause.
Syndrome | Primary Population | Key Characteristics |
Cowden syndrome | Adults | Benign and malignant tumors in the breast, thyroid, and uterus |
Bannayan-Riley-Ruvalcaba syndrome (BRRS) | Children | Skin tumors, birthmarks, and developmental delays |
What are the symptoms and signs of PTEN hamartoma tumor syndrome (PHTS)?
PHTS symptoms are highly variable and depend on which tissues are affected. Because the PTEN mutation affects cell growth throughout the body, signs can show up on the skin, in internal organs, and even in neurological development.
Common clinical signs include:
Skin and oral growths: Skin tags, trichilemmomas (small facial growths), lipomas, and oral fibromas.
Benign internal tumors: Thyroid nodules, goiters, uterine fibroids, and polyps in the gastrointestinal tract.
Physical and developmental traits: Macrocephaly (enlarged head size), developmental delays, and autism spectrum disorder.
Cancer risks: A significantly higher risk of breast, thyroid, kidney, uterine, and colorectal cancers, as well as melanoma. [1]
What causes PTEN hamartoma tumor syndrome and how is it inherited?
PHTS is an inherited genetic condition with an autosomal dominant pattern: a child has a 50% chance of inheriting the mutated gene if one biological parent carries it. In some cases the mutation is "de novo," arising spontaneously during early embryonic development in people with no family history. [1]
At the core of the syndrome, the PTEN enzyme fails to tell cells when to stop dividing or when to undergo apoptosis (programmed cell death). That failure produces the tissue overgrowth that defines the syndrome.
How is PTEN hamartoma tumor syndrome diagnosed and managed?
Diagnosis is confirmed with genetic testing, typically a blood test to find the PTEN mutation. Because cancer risks are higher, people diagnosed with PHTS, particularly those with Cowden syndrome, need lifelong surveillance.
Management strategies include:
Cancer screening: Regular mammograms, breast MRIs, colonoscopies, and thyroid ultrasounds to catch cancers at the earliest stage.
Surgical intervention: Removal of bothersome or suspicious growths with surgery, cryotherapy, or laser ablation.
Multidisciplinary care: A team of specialists, including geneticists, dermatologists, and oncologists, is often needed to address the diverse needs of each patient. [1]
Conclusion and Next Steps
PTEN hamartoma tumor syndrome is a complex condition that calls for proactive, lifelong medical engagement. There is no cure, but early diagnosis through genetic testing and careful cancer screening can greatly improve outcomes. If you have a family history of PHTS or several of the characteristic growths, talk with a genetic counselor or healthcare provider about testing and a personalized management plan.
Frequently Asked Questions
What does PHTS stand for?
PHTS stands for PTEN Hamartoma Tumor Syndrome, named after the mutated gene and the characteristic benign growths it causes. [1]
Is PHTS a form of cancer?
No, PHTS is a genetic syndrome that causes benign growths and increases the risk of developing certain cancers. [1]
How is PHTS inherited?
PHTS is inherited in an autosomal dominant pattern, meaning there is a 50% chance of passing it to offspring. [1]
What is a hamartoma?
A hamartoma is a benign, noncancerous growth that looks like a tumor but is made of normal tissue elements. [1]
Which cancers are most associated with Cowden syndrome?
Breast, thyroid, kidney, uterine, and colorectal cancers are the most common risks. [1]
Can PHTS be cured?
There is currently no cure for the underlying genetic mutation, but the symptoms and risks are highly manageable. [1]
What is macrocephaly in PHTS?
Macrocephaly refers to an unusually large head size, which is a common physical trait in both children and adults with PHTS. [1]
How is the condition diagnosed?
Diagnosis is confirmed through a genetic blood test that identifies a mutation in the PTEN gene. [1]
What are trichilemmomas?
Trichilemmomas are small, smooth, noncancerous growths that typically form on the face of individuals with PHTS. [1]
Why is lifelong screening necessary?
Because of the significantly increased risk of various cancers, regular screening is essential for early detection and treatment. [1]
References
Cleveland Clinic. PTEN Hamartoma Tumor Syndrome. Cleveland Clinic Health Library. Last updated December 16, 2022. https://my.clevelandclinic.org/health/diseases/24548-pten-hamartoma-tumor-syndrome
Hendricks LAJ, Hoogerbrugge N, Schuurs-Hoeijmakers JHM, et al. A review on age-related cancer risks in PTEN hamartoma tumor syndrome. Clin Genet. 2021;99(2):219-225. PMID: 33140411. DOI: 10.1111/cge.13875
Nieuwenhuis MH, Kets CM, Murphy-Ryan M, et al. Is colorectal surveillance indicated in patients with PTEN mutations? Colorectal Dis. 2012;14(9):e562-e566. PMID: 22672595. DOI: 10.1111/j.1463-1318.2012.03121.x
Takayama T, Muguruma N, Igarashi M, et al. Clinical Guidelines for Diagnosis and Management of Cowden Syndrome/PTEN Hamartoma Tumor Syndrome in Children and Adults-Secondary Publication. J Anus Rectum Colon. 2023;7(4):284-300. PMID: 37900693. DOI: 10.23922/jarc.2023-028
Medical disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have about a medical condition.
Comments